Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gastroenterologia Japonica|June 1, 1990
Immunohistochemical study of pre-S(2) antigen in liver and serum of patients with chronic hepatitis BK Takaguchi, G Yamada, T Tsuji
Epidemiology and Infection|March 7, 2014
Changes in hepatitis C virus genotype distribution in JapanH Toyoda, T Kumada, K Takaguchi, et al.
Public Health in Practice (Oxford, England)|February 8, 2024
Impact of COVID-19 on the mental health of primary schoolchildren during the later phase of the pandemic: A case report of an 18-month longitudinal survey in a Japanese primary schoolC Abe, K Shimatani, K Tsumura, et al.
Journal of Viral Hepatitis|December 17, 2016
Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in JapanH Toyoda, T Tada, K Takaguchi, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis BG Yamada, K Takaguchi, K Matsueda, et al.
Internal Medicine (Tokyo, Japan)|February 1, 1992
Four cases with intrafamilial clustering of hepatitis C virus infectionM Takahashi, G Yamada, T Doi, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitisY Miyake, Y Iwasaki, R Terada, et al.
British Journal of Cancer|September 19, 2013
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinomaK Miyahara, K Nouso, Y Morimoto, et al.
ESMO Open|November 30, 2021
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibM Rimini, M Kudo, T Tada, et al.
ESMO Open|October 8, 2022
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysisM Rimini, L Rimassa, K Ueshima, et al.
Pageof 1